Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche hires new inflammation and virology head

This article was originally published in Scrip

Executive Summary

Roche has appointed Jacques Banchereau head of its inflammation and virology R&D unit. Mr Banchereau will oversee R&D in autoimmune and respiratory diseases as rheumatoid arthritis and chronic obstructive pulmonary disease as well as in hepatitis, HIV, influenza and other infectious diseases. He will relocate to the Roche's R&D site in Nutley, New Jersey where the company's inflammation and virology unit is headquartered. He also will serve as Roche Nutley's Chief Scientific Officer. After working for Schering-Plough for 15 years, Mr Banchereau founded and was director of the Baylor Institute for Immunology Research in Dallas, Texas.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts